Vascular endothelial growth factor gene polymorphisms in Japanese patients with sarcoidosis

Chest

Volumn 123, Issue 5, 2003, Pages 1520-1526

  Morohashi, Kazuaki ^a   Takada, Toshinori ^a   Omori, Kentaro ^a   Suzuki, Eiichi ^a   Gejyo, Fumitake ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Genetic susceptibility; Polymorphism; Sarcoidosis; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL ACTIVATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA EXTRACTION; DNA POLYMORPHISM; EPITHELIOID CELL; FEMALE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENE LOCATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GIANT CELL; HUMAN; HUMAN CELL; JAPAN; LUNG ALVEOLUS MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SARCOIDOSIS;

EID: 0037879056     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.5.1520     Document Type: Article

References (33)

1. Mikami R, Sekiguchi M, Ryuzin Y, et al. Changes in the peripheral vasculature of various organs in patients with sarcoidosis: possible role of microangiopathy. Heart Vessels 1986; 2:129-139
2. Meyer KC, Kaminski MJ, Calhoun WJ, et al. Studies of bronchoalveolar lavage cells and fluids in pulmonary sarcoidosis: I. Enhanced capacity of bronchoalveolar lavage cells from patients with pulmonary sarcoidosis to induce angiogenesis in vivo. Am Rev Respir Dis 1989; 140:1446-1449
3. Ferrara N, Houck K, Jakeman L, et al. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13:18-32
4. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18:4-25
5. Rahimi N, Dayanir V, Lashkari K. Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells. J Biol Chem 2000; 275:16986-16992
6. Barleon B, Sozzani S, Zhou D, et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996; 87:3336-3343
7. Clauss M, Weich H, Breier G, et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities: implications for a functional role of placenta growth factor in monocyte activation and chemotaxis J Biol Chem 1996; 271:17029-17634
8. Tolnay E, Kuhnen C, Voss B, et al. Expression and localization of vascular endothelial growth factor and its receptor flt in pulmonary sarcoidosis. Virchows Arch 1998; 432:61-65
9. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the EBS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160:736-755
10. Niimi T, Tomita H, Sato S, et al. Vitamin D receptor gene polymorphism in patients with sarcoidosis. Am J Respir Crit Care Med 1999; 160:1107-1109
11. Petrek M, Drabek J, Kolek V, et al. CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 2000; 162:1000-1003
12. Takada T, Suzuki E, Ishida T, et al. Polymorphism in RANTES chemokine promoter affects extent of sarcoidosis in a Japanese population. Tissue Antigens 2001; 58:293-298
13. Yamaguchi E, Itoh A, Hizawa N, et al. The gene polymorphism of tumor necrosis factor-β, but not that of tumor necrosis factor-α, is associated with the prognosis of sarcoidosis. Chest 2001; 119:753-761
14. Brogan IJ, Khan N, Isaac K, et al. Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 1999; 60:1245-1249
15. Watson CJ, Webb NJ, Bottomley MJ, et al. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000; 12:1232-1235
16. Renner W, Kotschan S, Hoffmann C, et al. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000; 37:443-448
17. Asai T, Ohkubo T, Katsuya T, et al. Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama study. Hypertension 2001; 38:1321-1324
18. Schneider S, Boessli D, Excoffier L. Arlequin: a software for population genetics data analysis. Version 2.000. Geneva, Switzerland: Genetics and Biometry Laboratory, Department of Anthropology, University of Geneva, 2000
19. Flamme I, Frolich T, Risau W. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol 1997; 173:206-210
20. Peters KG, De Vries C, Williams LT. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci U S A 1993; 90:8915-8919
21. Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380:439-442
22. Hu YF, Luseher B, Admon A, et al. Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity. Genes Dev 1990; 4:1741-1752
23. Mermod N, Williams TJ, Tjian R. Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro. Nature 1988; 332:557-561
24. Comb M, Mermod N, Hyman SE, et al. Proteins bound at adjacent DNA elements act synergistically to regulate human proenkephalin cAMP inducible transcription. EMBO J 1988; 7:3793-3805
25. Berse B, Brown LF, Van de Water L, et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992; 3:211-220
26. Hoshino M, Nakamura Y, Harold QA. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol 2001; 107:1034-1038
27. Awata T, Inoue K, Kurihara S, et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002; 51:1635-1639
28. Shahbazi M, Fryer AA, Pravica V, et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 2002; 13:260-264
29. Bailey-Wilson JE, Sorant B, Sorant AJ, et al. Model-free association analysis of a rare disease. Genet Epidemiol 1995; 12:571-575
30. Ballara S, Taylor PC, Reusch P, et al. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum 2001; 44:2055-2064
31. Kasama T, Shiozawa F, Kobayashi K, et al. Vascular endothelial growth factor expression by activated synovial leukocytes in rheumatoid arthritis: critical involvement of the interaction with synovial fibroblasts. Arthritis Rheum 2001; 44:2512-2524
32. Kanazawa S, Tsunoda T, Onuma E, et al. VEGF, basic-FGF, and TGF-β in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol 2001; 96:822-828
33. McColley SA, Stellmach V, Boas SR, et al. Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am J Respir Crit Care Med 2000; 161:1877-1880